Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018

世界の組織診断(Tissue Diagnostics)市場動向と予測(~2018)

◆タイトル:Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018
◆商品コード:MD 2349
◆調査・発行会社:MarketsandMarkets
◆発行日:2014年4月
◆ページ数:267
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User(~5名)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate licence (社内共有可) USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界の組織診断(Tissue Diagnostics)市場動向と予測(~2018)"について調査・分析し、イントロダクション、エグゼクティブサマリー、プレミアムインサイト、市場概観、市場の動態、技術別分析、製品別分析、需要先別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

Tissue diagnostics is used to determine the stage, prognosis, and treatment course of cancer. According to estimates by the International Agency for Research on Cancer (ICRA) and World Health Organization (WHO), 19.3 million new cancer cases are expected to be detected per year by 2025, up from the 14.1 million new cases reported in 2012. The rapidly increasing incidence of cancer is the most important growth driver for the tissue diagnostics market in the forecast period from 2013 to 2018.

Advanced age is considered to be an important risk factor for cancer. People over 65 years of age account for close to 60% of all new cancer cases and close to 70% of all cancer deaths. The rapidly aging global population is expected to further drive the demand for tissue diagnostic products by 2018. Furthermore, increasing research funding for cancer has helped underline the importance of personalized medicine for cancer treatment. Tissue diagnostic-based companion diagnostics kits enable the identification of patients most likely to benefit from candidate drug products. The increasing use of personalized medicine is expected to further drive the market for tissue diagnostic products.

The report segments the global tissue diagnostics market by technology, disease, product, end user, and geography. Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market included in this report. The disease segments included in this report are breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other diseases segments. The end-user segments of the tissue diagnostics market included in this report are hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users like reference laboratories. The report maps the technology, disease, product, and end-user profiles in each of the 20 regional and geographic segments. It provides a granular understanding of the current market size and provides a market forecast for 2018.

A combination of bottom-up and top-down approaches were used to calculate the market size and growth rates of the global tissue diagnostics market and its sub-segments. Secondary information was used to identify overall revenues, geographic reach, and product portfolios of market players. Estimates of their tissue diagnostics segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in the growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important sub-segments. It maps the market sizes and growth rates of each sub-segment and identifies the segments poised for rapid growth in each of the 20 geographic and regional segments. The report also includes the company profiles of market leaders. The profiles include financial performance, product portfolios, and market developments for each company. The report also provides a competitive landscape of these market leaders and identifies the key growth strategies in this market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios of top players in the tissue diagnostics market. The report analyzes the tissue diagnostics market by technology, disease, and end users across geographies
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the tissue diagnostics market
• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the tissue diagnostics market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various tissue diagnostic products across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the tissue diagnostics market

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 18)
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Secondary Research
1.5.2 Primary Research
1.5.2.1 Key Data Points From Primary Sources
1.5.3 Market Size Estimation Methodology
1.5.4 Market Forecast
1.5.5 Market Data Validation & Data Triangulation
1.6 Assumptions

2 Executive Summary (Page No. – 30)

3 Premium Insights (Page No. – 34)

4 Market Overview (Page No. – 41)
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Drivers
4.3.1.1 Rising Incidence Of Cancer Is The Primary Driver For The Tissue Diagnostics Market
4.3.1.2 Rapidly Aging Population Will Increase The Disease Burden Of Non-Communicable Diseases
4.3.1.3 Increased Use Of Personalized Medicine For Cancer Will Drive The Demand For Tissue-Based Companion Diagnostic Tests
4.3.1.4 Growth in The Ivd Market Will Aid The Growth Of The Tissue Diagnostics Market
4.3.2 Restraints
4.3.2.1 Lack Of Budget To Restrict The Growth Of The Market
4.3.2.2 Stringent Regulatory Framework Acts As A Major Challenge For The Tissue Diagnostics Market
4.4 Market Share Analysis
4.5 Porter’s Analysis
4.5.1 Threat From New Entrants
4.5.2 Threat From Substitutes
4.5.3 Bargaining Power Of Buyers
4.5.4 Bargaining Power Of Suppliers
4.5.5 Competitive Rivalry Among Existing Players

5 Global Tissue Diagnostics Market, By Technology (Page No. – 55)
5.1 Introduction
5.2 Immunohistochemistry (IHC)
5.3 In Situ Hybridization (ISH)
5.4 Digital Pathology and Workflow Management
5.5 Special Staining

6 Global Tissue Diagnostics Market, By Disease (Page No. – 68)
6.1 Introduction
6.2 Breast Cancer
6.3 Gastric Cancer
6.4 Lymphoma
6.5 Prostate Cancer
6.6 Non-Small Cell Lung Carcinoma (NSCLC)
6.7 Other Diseases

7 Global Tissue Diagnotics Market, By Product (Page No. – 85)
7.1 Introduction
7.2 Instruments
7.3 Consumables

8 Global Tissue Diagnostics Market, By End User (Page No. – 93)
8.1 Introduction
8.2 Hospitals
8.3 Pharmaceutical Companies
8.4 Research Laboratories
8.5 Contract Research Organizations (CRO)
8.6 Other End-Users

9 Geographic Analysis (Page No. – 105)
9.1 Introduction
9.2 The Americas
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.2.4 Chile
9.2.5 Rest Of Americas (ROA)
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 Italy
9.3.4 Spain
9.3.5 U.K.
9.3.6 Rest Of Europe (ROE)
9.4 BRIC
9.4.1 Brazil
9.4.2 China
9.4.3 India
9.4.4 Russia
9.5 Japan
9.6 Rest Of The World (ROW)

10 Competitive Landscape (Page No. – 195)
10.1 Introduction
10.2 New Product Launches
10.3 Agreements, Collaborations, Expansions, Joint Ventures and Partnerships
10.4 Mergers and Acquisitions
10.5 Other Developments

11 Company Profiles (Business Overview, Products & Services, Key Strategy, & Recent Developments)* (Page No. – 204)
11.1 Abbott Laboratories, Inc.
11.2 Agilent Technologies
11.3 Biogenex Laboratories
11.4 Bio Sb.
11.5 Cell Signalling Technology, Inc.
11.6 Danaher Corporation.
11.7 Life Technologies
11.8 Roche
11.9 Sigma Aldrich
11.1 Thermo Fisher Scientific

*Details on Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case Of Unlisted Companies.

Appendix (Page No. – 251)

List Of Tables (97 Tables)

Table 1 Global Tissue Diagnostics Market, By Technology, 2011–2018 ($Million)
Table 2 Global IHC Market, By Geography, 2011–2018 ($Million)
Table 3 Global ISH Market, By Geography, 2011–2018 ($Million)
Table 4 Global Digital Pathology and Workflow Management Market, By Geography, 2011–2018 ($Million)
Table 5 Global Special Staining Market, By Geography, 2011–2018 ($Million)
Table 6 Global Market, By Disease, 2011–2018 ($Million)
Table 7 Global Breast Cancer Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 8 Global Gastric Cancer Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 9 Global Lymphoma Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 10 Global Prostate Cancer Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 11 Global NSCLC Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 12 Global Other Diseases Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 13 Global Market, By Product, 2011–2018 ($Million)
Table 14 Global Tissue Diagnostics Instruments Market, By Geography, 2011–2018 ($Million)
Table 15 Global Tissue Diagnostics Consumables Market, By Geography, 2011–2018 ($Million)
Table 16 Global Tissue Diagnostics Market, By End User, 2011–2018 ($Million)
Table 17 Global Hospitals Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 18 Global Pharmaceutical Companies Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 19 Global Academic Research Laboratories Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 20 Global CRO Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 21 Global Other End-Users Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 22 Global Tissue Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 23 The Americas: Market, By Geography, 2011–2018 ($Million)
Table 24 U.S.: Market, By Technology, 2011–2018 ($Million)
Table 25 U.S.: Market, By Disease, 2011–2018 ($Million)
Table 26 U.S.: Market, By Product, 2011–2018 ($Million)
Table 27 U.S.: Market, By End User, 2011–2018 ($Million)
Table 28 Canada: Market, By Technology, 2011–2018 ($Million)
Table 29 Canada: Market, By Disease, 2011–2018 ($Million)
Table 30 Canada: Market, By Product, 2011–2018 ($Million)
Table 31 Canada: Market, By End User, 2011–2018 ($Million)
Table 32 Mexico: Market, By Technology, 2011–2018 ($Million)
Table 33 Mexico: Market, By Disease, 2011–2018 ($Million)
Table 34 Mexico: Market, By Product, 2011–2018 ($Million)
Table 35 Mexico: Market, By End User, 2011–2018 ($Million)
Table 36 Chile: Market, By Technology, 2011–2018 ($Million)
Table 37 Chile: Market, By Disease, 2011–2018 ($Million)
Table 38 Chile: Market, By Product, 2011–2018 ($Million)
Table 39 Chile: Market, By End User, 2011–2018 ($Million)
Table 40 ROA: Market, By Technology, 2011–2018 ($Million)
Table 41 ROA: Market, By Disease, 2011–2018 ($Million)
Table 42 ROA: Market, By Product, 2011–2018 ($Million)
Table 43 ROA: Market, By End User, 2011–2018 ($Million)
Table 44 Europe: Market, By Geography, 2011–2018 ($Million)
Table 45 Germany: Market, By Technology, 2011–2018 ($Million)
Table 46 Germany: Market, By Disease, 2011–2018 ($Million)
Table 47 Germany: Market, By Product, 2011–2018 ($Million)
Table 48 Germany: Market, By End User, 2011–2018 ($Million)
Table 49 France: Market, By Technology, 2011–2018 ($Million)
Table 50 France: Market, By Disease, 2011–2018 ($Million)
Table 51 France: Market, By Product, 2011–2018 ($Million)
Table 52 France: Market, By End User, 2011–2018 ($Million)
Table 53 Italy: Market, By Technology, 2011–2018 ($Million)
Table 54 Italy: Market, By Disease, 2011–2018 ($Million)
Table 55 Italy: Market, By Product, 2011–2018 ($Million)
Table 56 Italy: Market, By End User, 2011–2018 ($Million)
Table 57 Spain: Market, By Technology, 2011–2018 ($Million)
Table 58 Spain: Market, By Disease, 2011–2018 ($Million)
Table 59 Spain: Market, By Product, 2011–2018 ($Million)
Table 60 Spain: Market, By End User, 2011–2018 ($Million)
Table 61 U.K.: Market, By Technology, 2011–2018 ($Million)
Table 62 U.K.: Market, By Disease, 2011–2018 ($Million)
Table 63 U.K.: Market, By Product, 2011–2018 ($Million)
Table 64 U.K.: Market, By End User, 2011–2018 ($Million)
Table 65 ROE: Market, By Technology, 2011–2018 ($Million)
Table 66 ROE: Market, By Disease, 2011–2018 ($Million)
Table 67 ROE: Market, By Product, 2011–2018 ($Million)
Table 68 ROE: Market, By End User, 2011–2018 ($Million)
Table 69 BRIC: Market, By Geography, 2011–2018 ($Million)
Table 70 Brazil: Market, By Technology, 2011–2018 ($Million)
Table 71 Brazil: Market, By Disease, 2011–2018 ($Million)
Table 72 Brazil: Market, By Product, 2011–2018 ($Million)
Table 73 Brazil: Market, By End User, 2011–2018 ($Million)
Table 74 China: Market, By Technology, 2011–2018 ($Million)
Table 75 China: Market, By Disease, 2011–2018 ($Million)
Table 76 China: Market, By Product, 2011–2018 ($Million)
Table 77 China: Market, By End User, 2011–2018 ($Million)
Table 78 India: Market, By Technology, 2011–2018 ($Million)
Table 79 India: Market, By Disease, 2011–2018 ($Million)
Table 80 India: Market, By Product, 2011–2018 ($Million)
Table 81 India: Market, By End User, 2011–2018 ($Million)
Table 82 Russia: Market, By Technology, 2011–2018 ($Million)
Table 83 Russia: Market, By Disease, 2011–2018 ($Million)
Table 84 Russia: Market, By Product, 2011–2018 ($Million)
Table 85 Russia: Market, By End User, 2011–2018 ($Million)
Table 86 Japan: Market, By Technology, 2011–2018 ($Million)
Table 87 Japan: Market, By Disease, 2011–2018 ($Million)
Table 88 Japan: Market, By Product, 2011–2018 ($Million)
Table 89 Japan: Market, By End User, 2011–2018 ($Million)
Table 90 ROW: Market, By Technology, 2011–2018 ($Million)
Table 91 ROW: Market, By Disease, 2011–2018 ($Million)
Table 92 ROW: Market, By Product, 2011–2018 ($Million)
Table 93 ROW: Market, By End User, 2011–2018 ($Million)
Table 94 New Product Launch, 2010–2014
Table 95 Agreements, Partnerships, Collaborations & Joint Ventures, 2010–2014
Table 96 Mergers and Acquisitions, 2010–2014
Table 97 Other Developments, 2010–2014

List Of Figures (37 Figures)

Figure 1 Research Methodology
Figure 2 Market Size Estimation Methodology
Figure 3 Market Forecasting Model
Figure 4 Data Triangulation Methodology
Figure 5 Global Tissue Diagnostics Market By Technology, 2013 Vs. 2018 ($Million)
Figure 6 Global Market, By Disease, 2013 Vs. 2018 ($Million)
Figure 7 Global Market, By End User, 2013 Vs. 2018 ($Million)
Figure 8 Global Market, By Geography, 2013 Vs. 2018 ($Million)
Figure 9 Global Market, Geographic Analysis, 2013 ($Million)
Figure 10 Global Market, By Disease, 2013
Figure 11 Global Market, By Disease, 2013 Vs. 2018
Figure 12 Global Market, By Disease, 2011–2018 (Market Sizes & Growth Rates)
Figure 13 Global Market, By Technology, 2013
Figure 14 Global Market, By Technology, 2013 Vs. 2018
Figure 15 Global Market, By Technology, 2011–2018 (Market Sizes & Growth Rates)
Figure 16 Global Market, By End User, 2013
Figure 17 Global Market, By End User, 2013 Vs. 2018
Figure 18 Global Market, By End User, 2011–2018 (Market Sizes & Growth Rates)
Figure 19 Market Segmentation
Figure 20 Market—Drivers & Restraints
Figure 21 Market Share Analysis, By Key Player, 2013
Figure 22 Porter’s Five Forces Analysis
Figure 23 Global Market Segmentation, By Technology
Figure 24 Global Market, By Technology, 2013–2018
Figure 25 Global Market Segmentation, By Disease
Figure 26 Global Market, By Disease, 2013–2018
Figure 27 Global Market Segmentation, By End Users
Figure 28 Global Market, By End User, 2013–2018
Figure 29 Global Market, By Region, 2013
Figure 30 Key Growth Strategies, Tissue Diagnostics Market, 2010-2014
Figure 31 Abbott Laboratories, Inc. Overview
Figure 32 Agilent Technologies Overview
Figure 33 Danaher Corporation. Overview
Figure 34 Life Technologies Overview
Figure 35 Roche Overview
Figure 36 Sigma Aldrich Overview
Figure 37 Thermo Fisher Scientific Overview

★調査レポート[世界の組織診断(Tissue Diagnostics)市場動向と予測(~2018)] ( Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018 / MD 2349) 販売に関する免責事項
[世界の組織診断(Tissue Diagnostics)市場動向と予測(~2018)] ( Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018 / MD 2349) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆